Freebird Partners LP - 10%+ Owner at Ernexa Therapeutics Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
ERNA, ERNAW on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Freebird Partners LP since 19 Jul 2025

Reported holdings for Freebird Partners LP in Ernexa Therapeutics Inc.

Form 4 holding 10%+ Owner

Eterna Therapeutics Inc.

Security class
Convertible Note Shares
Shares / value
783,233
Estimated value
$1,503,337
Report date
15 Dec 2023
Price
$1.92
Ownership
Direct
Underlying class
Common Stock, par value $0.005 per share
Underlying amount
Form 4 holding 10%+ Owner

Eterna Therapeutics Inc.

Security class
Common Stock Purchase Warrant
Shares / value
1,991,394
Estimated value
Report date
15 Dec 2023
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.005 per share
Underlying amount

Transaction history for Freebird Partners LP in Ernexa Therapeutics Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .